Document Detail


Modalities of the food intake-reducing effect of sibutramine in humans.
MedLine Citation:
PMID:  10716539     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sibutramine is a serotonin and noradrenaline reuptake inhibitor exerting a weight reducing effect partly via its anorectic properties. We investigated the effects of 15 mg sibutramine on objective (intake) and subjective (sensations) parameters of eating behavior in 24 young male subjects. At 0830 h subjects took either placebo or sibutramine in a counterbalanced order, followed by a fixed amount of breakfast. Intake was covertly recorded in the laboratory until the dinner meal, and then until the next morning using diary reports. Sibutramine induced a highly significant reduction in energy (1304 kJ, p < 0.001), protein (294 kJ, p < 0.001), fat (414 kJ, p < 0.01), and carbohydrate (CHO, 594 kJ, p < 0.001) intakes compared to placebo. This reduction was further enhanced when 24-h intake was analyzed (1601 kJ, p < 0.001). The effect of sibutramine occurred mainly at lunch (637 kJ, p = 0.005). Throughout the test day the number of items consumed and the weight of food were reduced by sibutramine (1.6, p < 0.01 and 222 g, p < 0.001, respectively), whereas energy density was not changed. Meals minus dessert items were the most altered by sibutramine. A specific CHO reduction was found in the dinner meal, although the proportions of macronutrients in total daily energy intake were not changed by sibutramine. Hunger ratings began to be lower than placebo 240 min after sibutramine. These results show that a single dose of sibutramine in lean humans induces a potent reduction in intake, and that its action is modulated according to the time of occurrence and the structure of the meal.
Authors:
D Chapelot; C Marmonier; F Thomas; C Hanotin
Related Documents :
2620939 - Conditioned taste aversion in lesser bandicoot rat, bandicota bengalensis.
15883549 - Relative validity and reliability of a food frequency questionnaire for a triethnic pop...
9218889 - A new triad: sensitivity to aspirin, allergic rhinitis, and severe allergic reaction to...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Physiology & behavior     Volume:  68     ISSN:  0031-9384     ISO Abbreviation:  Physiol. Behav.     Publication Date:  2000 Jan 
Date Detail:
Created Date:  2000-05-15     Completed Date:  2000-05-15     Revised Date:  2010-02-25    
Medline Journal Info:
Nlm Unique ID:  0151504     Medline TA:  Physiol Behav     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  299-308     Citation Subset:  IM    
Affiliation:
Laboratoire de Physiologie du Comportement Alimentaire, Nutrition et Maladies Metaboliques, UFR Sant?, M?decine et Biologie Humaine L?onard de Vinci, Bobigny, France. comp-alim@smbh.univ-paris13.fr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Appetite Depressants / pharmacology*
Cross-Over Studies
Cyclobutanes / pharmacology*
Diet Records
Double-Blind Method
Eating / drug effects*
Energy Intake / drug effects*
Food Habits / drug effects*
Humans
Male
Satiety Response / drug effects
Chemical
Reg. No./Substance:
0/Appetite Depressants; 0/Cyclobutanes; 106650-56-0/sibutramine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Involvement of central beta-adrenoceptors in the tachycardia induced by water immersion stress in ra...
Next Document:  Social stability attenuates the stress in the modified multiple platform method for paradoxical slee...